Nektar Therapeutics (NKTR) financial statements (2021 and earlier)

Company profile

Business Address 455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,0621,3251,335296389309238
Cash and cash equivalents199961955605612
Short-term investments8631,2281,140291329253225
Restricted cash and investments      25
Receivables393743516204
Inventory, net of allowances, customer advances and progress billings15131111111113
Inventory15131111111113
Other current assets1815211510109
Other undisclosed current assets43226    
Total current assets:1,1381,4221,438327426350288
Noncurrent Assets
Operating lease, right-of-use asset126 
Property, plant and equipment60654947667170
Long-term investments and receivables13727958357   
Long-term investments13727958357   
Intangible assets, net (including goodwill)77777777777777
Goodwill77777777777777
Other noncurrent assets1141147
Other undisclosed noncurrent assets 134     
Total noncurrent assets:401556712182143152153
TOTAL ASSETS:1,5391,9772,150509569502442
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46462927301722
Accounts payable221965323
Accrued liabilities1011910546
Employee-related liabilities15111081866
Interest and dividends payable 444447
Deferred revenue0 
Debt 249  355
Deferred revenue and credits19142124
Contract with customer, liability614
Other liabilities 1004106
Other undisclosed current liabilities69523992088
Total current liabilities:1163548256726164
Noncurrent Liabilities
Long-term debt and lease obligation136 247245246243129
Long-term debt, excluding current maturities  247245243242125
Capital lease obligations  214
Operating lease, liability136 
Liabilities, other than long-term debt933031638192
Deferred revenue and credits25587177
Deferred revenue2 
Contract with customer, liability311
Deferred rent credit  9
Other liabilities7110651015
Other undisclosed noncurrent liabilities200215748999111120
Total noncurrent liabilities:346218351365409434341
Total liabilities:461572433421481496405
Stockholders' equity
Stockholders' equity attributable to parent1,0771,4051,7188888636
Common stock0000000
Additional paid in capital3,3893,2713,1482,2082,1111,8761,824
Accumulated other comprehensive loss(2)(1)(6)(2)(2)(2)(2)
Accumulated deficit(2,309)(1,865)(1,424)(2,118)(2,021)(1,867)(1,786)
Total stockholders' equity:1,0771,4051,7188888636
TOTAL LIABILITIES AND EQUITY:1,5391,9772,150509569502442

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1531151,193308165231201
Revenue, net66754325
Cost of revenue(50)(21)(24)(47)(30)(34)(32)
Cost of goods and services sold(19)(21)(24)(31)(30)(34)(32)
Gross profit:102931,169261135197169
Operating expenses(528)(533)(481)(321)(248)(226)(202)
Other undisclosed operating income      16
Operating income (loss):(425)(440)688(60)(113)(29)(16)
Nonoperating expense(19)(0)(5)(36)(40)(51)(38)
Other nonoperating income1846385221
Interest and debt expense(7)(21)(22)(22)(22)(14)(18)
Other undisclosed income from continuing operations before equity method investments, income taxes      18
Income (loss) from continuing operations before equity method investments, income taxes:(451)(461)661(118)(175)(95)(54)
Other undisclosed income from continuing operations before income taxes72122222214 
Income (loss) from continuing operations before income taxes:(444)(440)683(96)(153)(81)(54)
Income tax expense (benefit)(0)(1)(1)(1)(1)(1)1
Net income (loss) available to common stockholders, diluted:(444)(441)681(97)(154)(81)(54)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(444)(441)681(97)(154)(81)(54)
Other comprehensive income (loss)(1)5(4)0(0)(1)(0)
Comprehensive income (loss), net of tax, attributable to parent:(446)(435)677(96)(154)(82)(54)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: